
Results
9
Large established companies which pay a dividend.
9 companies
Sanofi
Market Cap: €90.3b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€75.25
7D
2.0%
1Y
-8.8%
Astellas Pharma
Market Cap: JP¥3.8t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,152.00
7D
0.3%
1Y
53.5%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,855.50
7D
3.6%
1Y
13.9%
Krka d. d
Market Cap: €7.8b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€257.50
7D
-1.7%
1Y
32.7%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,660.50
7D
4.4%
1Y
5.9%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,413.50
7D
1.5%
1Y
52.3%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥39.8b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥24.03
7D
8.4%
1Y
-22.6%
Abbott India
Market Cap: ₹546.6b
Operates as a pharmaceutical company in India.
500488
₹25,721.65
7D
0.5%
1Y
-27.5%
Livzon Pharmaceutical Group
Market Cap: CN¥23.9b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥30.39
7D
6.9%
1Y
-16.4%